Research Article

A Comparative Study of Oral Microbiota in Infants with Complete Cleft Lip and Palate or Cleft Soft Palate

Table 4

Development of the oral microbiota between T1 and T2 in CLP subjects.

Microorganism+→++→−§−→+#−→−pOR95% CI
(%) (%) (%) (%)

Streptococcus mitis19 (63)011 (37)00.006NANA
Streptococcus oralis1 (3)02 (6)27 (90)0.479NANA
Streptococcus pneumoniae1 (3)03 (10)21 (70)0.248NANA
Streptococcus sanguinis5 (16)1 (3)10 (33)14 (47)0.012101.28–78.12
Streptococcus salivarius7 (23)1 (3)22 (73)0<0.001222.96–16.21
Streptococcus vestibularis2 (6)1 (3)1 (3)26 (87)0.49720.18–22.05
Streptococcus bovis biovar I2 (6)6 (20)2 (6)20 (67)0.28830.72–49.83
Streptococcus acidominimus2 (6)02 (6)26 (87)0.497NANA
Streptococcus agalactiae002 (6)28 (93)0.497NANA
Streptococcus pyogenes004 (13)26 (87)0.125NANA
Streptococcusdysgalactiae02 (6)028 (93)0.497NANA
Streptococcus uberis1 (3)1 (3)1 (3)27 (90)1.0010.06–15.98
Streptococcus anginosus1 (3)1 (3)2 (6)26 (87)1.0020.18–22.05
Streptococcus intermedius5 (17)03 (10)22 (73)0.248NANA
Streptococcus constellatus3 (10)1 (3)1 (3)25 (83)1.0010.06–15.98
Lactobacillus spp.3 (10)1 (3)5 (17)21 (70)0.21850.58–42.79
Gemella haemolysans5 (17)03 (10)22 (73)0.248NANA
Gemella morbillorum06 (20)024 (80)0.041NANA
Enterococcus spp.2 (6)02 (6)26 (87)0.497NANA
Staphylococcus aureus MSSA12 (40)1 (3)16 (53)1 (3)<0.001162.12–12.65
Staphylococcus aureus MRSA01 (3)029 (97)1NANA
Staphylococcus xylosus04 (13)4 (13)26 (87)0.73310.25–3.99
Staphylococcus epidermidis9 (30)1 (3)16 (53)4 (13)<0.001162.12–12.65
Staphylococcus hominis1 (3)2 (6)3 (10)24 (80)11.50.25–8.97
Staphylococcus haemolyticus01 (3)029 (97)1NANA
Staphylococcus lugdunensis03 (10)027 (90)0.248NANA
Lactococcus lactis1 (3)03 (10)26 (87)0.248NANA
Neisseria spp.3 (10)2 (6)13 (43)12 (40)0.0076.51.46–28.80
Moraxella spp.01 (3)029 (97)1NANA
Acinetobacter lwoffii02 (6)028 (93)0.479NANA
Acinetobacter baumannii01 (3)029 (97)1NANA
Enterobacter cloacae3 (10)09 (30)18 (60)0.021NANA
Enterobacter kobei2 (6)1 (3)6 (20)21 (70)0.12560.72–49.83
Enterobacter aerogenes2 (6)02 (6)26 (87)0.479NANA
Enterobacter asburiae01 (3)029 (97)1NANA
Serratia liquefaciens02 (6)028 (93)0.479NANA
Serratia fonticola03 (10)027 (90)0.248NANA
Klebsiella pneumoniae5 (17)1 (3)11 (37)13 (43)0.006111.42–85.20
Klebsiella oxytoca4 (13)1 (3)18 (60)7 (23)<0.001182.40–13.83
Citrobacter spp.01 (3)029 (97)1NANA
Escherichia coli1 (3)5 (17)10 (33)14 (47)0.30120.68–5.85

Number () and percentage (%) of patients with the bacterial species present at both T1 and T2.
Number () and percentage (%) of patients with the bacterial species present at T1 but not at T2;
§Number () and percentage (%) of patients without the bacterial species present at T1 but with it at T2.
#Number () and percentage (%) of patients without the bacterial species present at T1 or T2.
Test; OR, odds ratio; 95% CI, confidence interval of 95%; NA, not applicable.
Results in boldface have reached statistical significance (p < 0.05).